Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.75 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.64 |
| ▸ | ALPI | P09923 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | XIAP | P98170 | 1/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL2311858 | 1.00 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL6585990 | 1.00 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL4757537 | 0.98 | SLC7A5 (0.73) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL6065563 | 0.98 | SLC7A5 (0.73) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL28027026 | 0.91 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Dl-Phenylalanine SCHEMBL5200313 | 0.90 | SLC7A5 (0.79) | SLC7A5PTGS1ALPIPKMXIAP | |
| Phenylalanine SCHEMBL7741736 | 0.90 | SLC7A5 (0.79) | SLC7A5PTGS1ALPIPKMXIAP | |
| Dl-Phenylalanine SCHEMBL7321619 | 0.89 | SLC7A5 (0.76) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL133206 | 0.89 | SLC7A5 (0.89) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1908049 | 0.89 | SLC7A5 (0.89) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4417221-A2 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2024-08-21 | — | — | EP | claimed |
| CN-115135694-B | Polymeric excipients for drug delivery applications | 廷德尔配方服务有限责任公司 | 2024-03-15 | — | — | CN | claimed |
| EP-4087543-B1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | TYNDALL FORMULATION SERVICES LLC (US) | 2024-03-06 | — | — | EP | claimed |
| US-11891482-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2024-02-06 | — | — | US | claimed |
| US-20230382949-A1 | LINEAR APELIN RECEPTOR AGONISTS | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-11-30 | — | — | US | claimed |
| CN-116730969-A | Beta-lapachone-amino acid conjugate, and preparation method and application thereof | 中国药科大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116710469-A | Linear Apelin receptor agonists | 赫帕雷斯治疗有限公司 | 2023-09-05 | — | — | CN | claimed |
| EP-4087543-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2022-11-16 | — | — | EP | claimed |
| CN-115135694-A | Polymeric excipients for drug delivery applications | 廷德尔配方服务有限责任公司 | 2022-09-30 | — | — | CN | claimed |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC | 2022-08-11 | — | — | US | claimed |
| US-11286344-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2022-03-29 | — | — | US | claimed |
| WO-2021141603-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2021-07-15 | — | — | WO | claimed |
| US-20210214496-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC | 2021-07-15 | — | — | US | claimed |
| CN-102503850-A | Hydroxyl-contained N-acylamino acid and preparation method thereof | UNIV TIANJIN | 2012-06-20 | — | — | CN | claimed |
| US-12077611-B2 | Cyclic peptides multimers targeting α4β7 integrin | ZEALAND PHARMA A/S (DK) | 2024-09-03 | — | — | US | disclosed |
| EP-4417221-A2 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| CN-116730969-B | Beta-lapachone-amino acid conjugate, and preparation method and application thereof | 中国药科大学 | 2024-04-19 | — | — | CN | disclosed |
| EP-1636164-A2 | PROCESS FOR PREPARING 3-ARYL-2-HYDROXY PROPANOIC ACID DERIVATIVES WITHOUT RESOLUTION | CADILA HEALTHCARE LTD. (IN) | 2006-03-22 | — | — | EP | disclosed |
| WO-2005019152-A2 | PROCESS FOR PREPARING 3-ARYL-2-HYDROXY PROPANOIC ACID DERIVATIVES WITHOUT RESOLUTION | CADILA HEALTHCARE LIMITED (IN) | 2005-03-03 | — | — | WO | disclosed |
| US-4043993-A | New pentapeptides and methods for their production | PARKE, DAVIS & COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286344-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-12077611-B2 | Cyclic peptides multimers targeting α4β7 integrin | ITGB7, ITGB4, ITGA4 | SLC7A5 2076/4885PTGS1 4545/4885ALPI 3864/4885 |
| US-11891482-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20210214496-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | CLTB, ACTB, TNNC1 | SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885 |
| US-20230382949-A1 | LINEAR APELIN RECEPTOR AGONISTS | APLNR, MTNR1A, EDNRA | SLC7A5 2228/4885PTGS1 1020/4885ALPI 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.